港股异动︱微盟集团涨近4%完成11.57亿港元新股配售腾讯和GIC继续增持
格隆汇8月1日丨智能商业服务提供商微盟集团(02013.HK)涨近4%,报4.23港元,成交6699万港元,总市值85亿港元。微盟集团昨晚发布公告,宣布公司于7月30日完成2.55亿股配售,筹集资金11.57亿港元,公司现有股东腾讯及GIC继续增持,分别通过其附属公司购入微盟集团2540万股、7200万股股份。微盟集团董事会认为,此次配售完成将对公司未来业务发展产生重大积极影响,充足的资金将有利于公司未来尽快完成智慧商业云服务生态布局,同时现有股东腾讯及GIC的增持也显示出股东对公司未来发展前景的信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.